Shambhavi Naik, Yazad Jal and Anirudh Kanisetti discuss the contentious issue of germline gene editing. Eminent scientists have called for a five year moratorium on clinical applications of germline concerning reproductive cells gene editing. Such a move will reduce funding and transnational research in congential diseases. In this episode, they discuss how proposing stringent safety standards would be more effective than an outright ban.